Extraordinary General Meeting Called: Business Purpose Expansion and Election of 5 Directors
An extraordinary general meeting will be held on June 5, 2026, with the record date for voting rights on May 6, 2026.
Through partial amendment of the articles of incorporation, 20 new business purposes will be added, including pet funeral services, clinical pathology services, overseas medical expansion, non-clinical/clinical trial consulting, and manufacturing/sales of bio-reagents and medical devices. Existing real estate and investment-related business purposes will be systematically reorganized.
The agenda includes the election of three inside directors (Kim Do-hyung, Kang Woo-hyun, Park Soo-hyun) and two outside directors (Noh Yoon-seok, Kang Jun-gu), each with a three-year term.
KOSDAQ Filing Information
Filing: [Correction of Description] Resolution on Convening of General Meeting of Shareholders (Extraordinary General Meeting)